Get Live Data

Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. GSK publishes provisional 2020 Dividend Dates

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,618.00
Bid: 1,615.00
Ask: 1,616.00
Change: 1.50 (0.09%)
Spread: 1.00 (0.062%)
Open: 1,619.50
High: 1,622.50
Low: 1,606.00
Prev. Close: 1,616.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GSK publishes provisional 2020 Dividend Dates

3 Feb 2020 15:15

RNS Number : 7940B
GlaxoSmithKline PLC
03 February 2020
 

GlaxoSmithKline plc

 

GSK publishes provisional dividend dates

 

 

 

The following amendment has been made to the 'GSK publishes 2020 Dividend Dates' announcement released on 8 January 2020 at 16:30 under RNS No 2038Z.

 

Q1 2020 Last date for DRIP elections amended to 18 June 2020.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Results announcement date

Ex-dividend date

Record date

Last date for DRIP elections

Payment date

Q1 2020

Wednesday

29 April

Thursday

14 May

Friday

15 May

Thursday

18 June

Thursday

9 July

Q2 2020

Wednesday

29 July

Thursday

13 August

Friday

14 August

Thursday

17 September

Thursday

8 October

Q3 2020

Wednesday

28 October

Thursday

12 November

Friday

13 November

Monday

21 December

Thursday

14 January 2021

Q4 2020

(Final)

Wednesday

3 February 2021

Thursday

18 February 2021

Friday

19 February 2021

Tuesday

16 March 2021

Thursday

8 April 2021

 

These dates are indicative and may be subject to change.

 

 

 

 

Victoria Whyte

Company Secretary

 

3 February 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZXLFBBLLEBBK
456789101112
Date   Source Headline
1st Apr 202211:20 amRNSGSK - segment and product sales reporting changes
28th Mar 20221:00 pmRNSPublication of 2022 AGM Notice
24th Mar 20223:22 pmRNSDirector/PDMR Shareholding
24th Mar 20222:00 pmRNSFDA update: Cabenuva oral lead-in now optional
23rd Mar 20225:03 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSIssuance of Notes
16th Mar 20222:40 pmRNSDirector/PDMR Shareholding
15th Mar 20222:45 pmRNSDirector/PDMR Shareholding
15th Mar 202210:00 amRNSAppointments to Designate Haleon Board
11th Mar 20222:55 pmRNSDirector/PDMR Shareholding
9th Mar 20221:44 pmRNSDirector/PDMR Shareholding
8th Mar 20226:24 pmRNSGSK Annual Report 2021 on Form 20-F
4th Mar 202211:03 amRNSGSK publishes Annual Report 2021
1st Mar 20222:30 pmRNSTotal Voting Rights
1st Mar 20221:18 pmRNSDirector/PDMR Shareholding
1st Mar 20229:55 amRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSDaprodustat application accepted for review by EMA
28th Feb 202211:00 amRNSGSK introduces Haleon to investors
28th Feb 20227:00 amRNSGSK RSV maternal vaccine candidate further update
24th Feb 20224:22 pmRNSDirector/PDMR Shareholding
24th Feb 20223:12 pmRNSCanada Approval For Medicago GSK Covid-19 Vaccine
23rd Feb 20222:50 pmRNSDirector/PDMR Shareholding
22nd Feb 20222:00 pmRNSGSK Consumer Healthcare to be called Haleon
22nd Feb 20229:22 amRNSDirector/PDMR Shareholding
18th Feb 20224:30 pmRNSDirector/PDMR Shareholding
18th Feb 20227:00 amRNSGSK gives update on RSV maternal vaccine candidate
17th Feb 20224:00 pmRNSDirector/PDMR Shareholding
17th Feb 20223:40 pmRNSDirector/PDMR Shareholding
17th Feb 20223:20 pmRNSDirector/PDMR Shareholding
17th Feb 20222:50 pmRNSDirector/PDMR Shareholding
17th Feb 20222:19 pmRNSDirector/PDMR Shareholding
16th Feb 20226:04 pmRNSDirector/PDMR Shareholding
14th Feb 20225:50 pmRNSDirector/PDMR Shareholding
14th Feb 20221:26 pmRNSTransfer of Treasury Shares
11th Feb 20222:06 pmRNSDirector/PDMR Shareholding
11th Feb 20229:33 amRNSDirector/PDMR Shareholding
10th Feb 20229:00 amRNSBenlysta approved in China for Lupus Nephritis
9th Feb 202211:07 amRNSDirector/PDMR Shareholding
9th Feb 20227:00 amRNSFinal Results
7th Feb 202210:30 amRNSPublication of full year 2021 results: Replacement
7th Feb 202210:00 amRNSPublication of full year 2021 results
2nd Feb 20227:00 amRNSGSK announces settlement between ViiV and Gilead
1st Feb 20221:44 pmRNSFDA approves ViiV Healthcare’s sNDA for Cabenuva
1st Feb 202211:44 amRNSTotal Voting Rights
26th Jan 20224:48 pmRNSDirector/PDMR Shareholding
20th Jan 20223:59 pmRNSDirector/PDMR Shareholding
19th Jan 20224:33 pmRNSDirector/PDMR Shareholding
19th Jan 20223:14 pmRNSDirector/PDMR Shareholding
19th Jan 20223:10 pmRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTony Wood appointed CSO Designate, GSK
456789101112

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.